Investissement Québec (IQ), the provincial government’s investment arm, and the Fonds de Solidarité FTQ, the venture capital fund of the province’s largest union federation, have each pledged $75 million over five years to support the province’s sizeable biotech and life-sciences sectors. (The Logic)
Talking point: Quebec biotech has been thriving as of late, particularly in the development of so-called “precision medicine,” which targets subgroups of people and therefore allows doctors to better predict treatment and prevention strategies. In November 2019, the Caisse de dépôt et placement du Québec, the Fonds and IQ, along with BDC Capital, invested in Toronto-based Amplitude Ventures’ $200-million fund, aiming to support precision-medicine development. The Fonds has also backed Repare Therapeutics, which is about to go public on the Nasdaq.